ArticleThe journal of obstetrics and gynaecology research2026
Obstetrical and Neonatal Outcomes in Pregnant Individuals With Anxiety Disorders.
Article in The journal of obstetrics and gynaecology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimAnxiety disorders (AD) are increasingly prevalent among the general population and pregnant individuals. Previous research has supported evidence of adverse obstetrical and fetal outcomes associated with pregnancies affected by mental health conditions. However, these studies often combine multiple psychiatric disorders, making it difficult to delineate the specific contribution of ADs. The purpose of the current study is to characterize the impact of ADs on obstetrical and fetal/neonatal outcomes.
methodsData from the 2016-2021 Healthcare Cost and Utilization Project, Nationwide Inpatient Sample, an American population-based database, were used to perform a retrospective cohort study. Associations between pregnancies with ADs and obstetrical and newborn outcomes were examined using multivariable logistic regression models adjusted for baseline maternal characteristics.
resultsWe identified 225 326 individuals with ADs and 4 112 286 individuals without ADs. The prevalence of ADs in pregnancy rose substantially from 3.1% to 8.1% of pregnancies between 2016 and 2021. Individuals with ADs were more likely to be Caucasian, had higher income, had private insurance, and had pre-existing comorbidities. ADs during pregnancy were associated with greater risks of multiple obstetrical complications including gestational hypertension, pre-eclampsia, preterm birth, postpartum hemorrhage, and longer hospital stay. Intrauterine growth restriction and congenital anomalies were more frequent among neonates born to individuals with ADs.
conclusionsPregnant individuals with ADs are at greater risk of experiencing adverse obstetrical and neonatal outcomes. Hence, it is critical for healthcare providers to screen pregnant patients for ADs and to provide appropriate treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.